Brief: ADAR1 Capital Management Calls For Keros Therapeutics To Restructure Business, Reduce Headcount

Keros Therapeutics

08/05/2025 19:14

May 8 (Reuters) - ADAR1 Capital Management:

ADAR1 CAPITAL MANAGEMENT: CALLS FOR KEROS TO RESTRUCTURE BUSINESS, SIGNIFICANTLY REDUCE HEADCOUNT, RETURN EXCESS CAPITAL TO STOCKHOLDERS

ADAR1 CAPITAL MANAGEMENT: TO "WITHHOLD" VOTES ON RE-ELECTION OF MARY ANN GRAY & ALPNA SETH AT KEROS THERAPEUTICS' ANNUAL MEETING OF STOCKHOLDERS

ADAR1 CAPITAL MANAGEMENT: URGED KEROS TO DISCONTINUE DEVELOPMENT OF KER-012 AND KER-065

Source text: ID:nPn3C2GWma

Further company coverage: KROS.O

 ((Reuters.Briefs@thomsonreuters.com;))